Giuseppe Gerna

Q: What Schools Are Affiliated With Giuseppe Gerna

Giuseppe Gerna is affiliated with the following schools: University of Milan, University of Melbourne, University of Pavia, Stanford University

Giuseppe Gerna's AcademicInfluence.com Rankings

Giuseppe Gerna

Computer Science

#7687

World Rank

#8091

Historical Rank

Machine Learning

#2923

World Rank

#2959

Historical Rank

Artificial Intelligence

#3219

World Rank

#3266

Historical Rank

Database

#4743

World Rank

#4926

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Giuseppe Gerna's Degrees

PhD Computer Science University of Milan
Masters Computer Science University of Milan
Bachelors Computer Science University of Milan

Similar Degrees You Can Earn

Why Is Giuseppe Gerna Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Giuseppe Gerna's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant (2002) (592)
Human Cytomegalovirus UL131-128 Genes Are Indispensable for Virus Growth in Endothelial Cells and Virus Transfer to Leukocytes (2004) (472)
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. (2014) (381)
Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the gH/gL/UL128-131A Complex (2009) (309)
Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia. (1991) (297)
Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication. (2002) (266)
Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia (1992) (255)
Are Human P[14] Rotavirus Strains the Result of Interspecies Transmissions from Sheep or Other Ungulates That Belong to the Mammalian Order Artiodactyla? (2009) (205)
Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells. (2005) (203)
Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. (1998) (193)
Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture (2010) (190)
High Levels of Epstein-Barr Virus DNA in Blood of Solid-Organ Transplant Recipients and Their Value in Predicting Posttransplant Lymphoproliferative Disorders (2000) (180)
Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients. (1992) (180)
Detection and Characterization of Novel Rotavirus Strains in the United States (1998) (179)
Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins (1990) (176)
Human Cytomegalovirus Replicates Abortively in Polymorphonuclear Leukocytes after Transfer from Infected Endothelial Cells via Transient Microfusion Events (2000) (174)
Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. (2008) (172)
Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS (1996) (171)
Fetal Human Cytomegalovirus Transmission Correlates with Delayed Maternal Antibodies to gH/gL/pUL128-130-131 Complex during Primary Infection (2013) (170)
Prevention of Primary Cytomegalovirus Infection in Pregnancy☆ (2015) (168)
Monitoring of Human Cytomegalovirus‐Specific CD4+ and CD8+ T‐Cell Immunity in Patients Receiving Solid Organ Transplantation (2006) (164)
Pathogenesis and prenatal diagnosis of human cytomegalovirus infection. (2004) (161)
Genetic variability of human coronavirus OC43‐, 229E‐, and NL63‐like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients (2006) (159)
Isolation and characterization of two distinct human rotavirus strains with G6 specificity (1992) (158)
Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. (1993) (155)
Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients (1994) (143)
Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications (2010) (143)
Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. (1989) (140)
The Human Cytomegalovirus Ribonucleotide Reductase Homolog UL45 Is Dispensable for Growth in Endothelial Cells, as Determined by a BAC-Cloned Clinical Isolate of Human Cytomegalovirus with Preserved Wild-Type Characteristics (2002) (127)
Clinical severity and molecular typing of human rhinovirus C strains during a fall outbreak affecting hospitalized patients. (2009) (125)
Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. (2002) (123)
Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. (1999) (123)
Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience. (2011) (122)
Pathogenesis of human cytomegalovirus infection and cellular targets. (2004) (122)
Association of BK virus with human brain tumors and tumors of pancreatic islets (1987) (121)
Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies (2014) (117)
Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus. (2007) (116)
Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients (2007) (113)
Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients (2009) (112)
Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viremia in immunocompromised patients (1989) (108)
A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate (1995) (107)
In vitro selection of human cytomegalovirus variants unable to transfer virus and virus products from infected cells to polymorphonuclear leukocytes and to grow in endothelial cells. (2001) (101)
Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants. (2006) (100)
Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients (2006) (99)
Virologic and Immunologic Monitoring of Cytomegalovirus to Guide Preemptive Therapy in Solid‐Organ Transplantation (2011) (98)
Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients. (1992) (98)
Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients. (1995) (94)
Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection (2008) (92)
Improved prenatal diagnosis of congenital human cytomegalovirus infection by a modified nested polymerase chain reaction (1998) (91)
Antibodies Against Neutralization Epitopes of Human Cytomegalovirus gH/gL/pUL128-130-131 Complex and Virus Spreading May Correlate with Virus Control In Vivo (2012) (90)
Monitoring human cytomegalovirus infection in transplant recipients. (2008) (90)
Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood (2011) (88)
Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by the polymerase chain reaction. (1993) (88)
In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia. (1998) (86)
Transmission of human cytomegalovirus from infected uterine microvascular endothelial cells to differentiating/invasive placental cytotrophoblasts. (2002) (84)
Quantification of Human Cytomegalovirus DNA in Amniotic Fluid of Mothers of Congenitally Infected Fetuses (1999) (84)
Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia. (2007) (82)
Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients (1992) (82)
Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood. (1998) (81)
Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs. (2004) (81)
Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection. (2008) (79)
Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays. (2010) (78)
Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. The Italian Foscarnet Study Group (1994) (77)
Interferon-gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells. (1998) (77)
Characterization of unusual G8 rotavirus strains isolated from Egyptian children (1999) (77)
Human cytomegalovirus viraemia in HIV-1-seropositive patients at various clinical stages of infection. (1990) (76)
Simultaneous quantification of human cytomegalovirus (HCMV)‐specific CD4+ and CD8+ T cells by a novel method using monocyte‐derived HCMV‐infected immature dendritic cells (2005) (75)
Isolation of an avianlike group A rotavirus from a calf with diarrhea (1992) (75)
Human Cytomegalovirus Immediate-Early mRNA Detection by Nucleic Acid Sequence-Based Amplification as a New Parameter for Preemptive Therapy in Bone Marrow Transplant Recipients (2000) (75)
Monoclonal antibodies versus reverse transcription‐PCR for detection of respiratory viruses in a patient population with respiratory tract infections admitted to hospital (2004) (74)
The Cys607→Tyr Change in the UL97 Phosphotransferase Confers Ganciclovir Resistance to Two Human Cytomegalovirus Strains Recovered from Two Immunocompromised Patients (1998) (70)
Serotyping of cell culture-adapted subgroup 2 human rotavirus strains by neutralization (1984) (70)
Human cytomegalovirus (HCMV) infection in paediatric patients given allogeneic bone allogeneic bone marrow transplantation: role of early antiviral treatment for HCMV antigenaemaia on Patients' outcome (1994) (70)
Standardization of the Human Cytomegalovirus Antigenemia Assay by Means of In Vitro-Generated pp65-Positive Peripheral Blood Polymorphonuclear Leukocytes (1998) (70)
Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial. (2003) (69)
Clinical Significance of Expression of Human Cytomegalovirus pp67 Late Transcript in Heart, Lung, and Bone Marrow Transplant Recipients as Determined by Nucleic Acid Sequence-Based Amplification (1999) (69)
Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections. (2011) (69)
Preconceptional primary human cytomegalovirus infection and risk of congenital infection. (2006) (68)
Human cytomegalovirus (HCMV) leukodnaemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection. (1998) (68)
Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients (1995) (68)
Evaluation of Cytomegalovirus DNAaemia versus pp65-Antigenaemia Cutoff for Guiding Preemptive therapy in Transplant Recipients: A Randomized Study (2007) (67)
Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers. (2006) (67)
Human enteric Coronaviruses: Antigenic Relatedness to Human Coronavirus OC43 and Possible Etiologic Role in Viral Gastroenteritis (1985) (66)
Polymerase chain reaction for prenatal diagnosis of congenital human cytomegalovirus infection (1995) (65)
Rapid Detection of Human Metapneumovirus Strains in Nasopharyngeal Aspirates and Shell Vial Cultures by Monoclonal Antibodies (2005) (65)
Genotypic analysis of two hypervariable human cytomegalovirus genes (2008) (64)
Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients (2008) (64)
The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders (1999) (63)
Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay. (1992) (63)
Correlation of viral load as determined by real-time RT-PCR and clinical characteristics of respiratory syncytial virus lower respiratory tract infections in early infancy. (2008) (62)
Detection and pathogenicity of human metapneumovirus respiratory infection in pediatric Italian patients during a winter–spring season (2005) (62)
Sequencing and Analysis of Globally Obtained Human Respiratory Syncytial Virus A and B Genomes (2015) (62)
Quantitation of herpes simplex virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis by the polymerase chain reaction. (1997) (60)
Human Cytomegalovirus Genomes Sequenced Directly From Clinical Material: Variation, Multiple-Strain Infection, Recombination, and Gene Loss (2019) (60)
Changing circulation rate of human metapneumovirus strains and types among hospitalized pediatric patients during three consecutive winter-spring seasons (2005) (59)
Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation (2016) (58)
Monitoring transplant patients for human cytomegalovirus: Diagnostic update. (2006) (58)
Identification of a new VP4 serotype of human rotaviruses. (1994) (56)
Monitoring of Human Cytomegalovirus and Virus-Specific T-Cell Response in Young Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (2012) (56)
Human rhinovirus and human respiratory enterovirus (EV68 and EV104) infections in hospitalized patients in Italy, 2008-2009. (2012) (55)
Geographic and demographic differences in the frequency of human cytomegalovirus gB genotypes 1-4 in immunocompromised patients. (1998) (55)
Prenatal diagnosis of rubella virus infection by direct detection and semiquantitation of viral RNA in clinical samples by reverse transcription-PCR (1997) (54)
Analysis of HIV drug‐resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment‐naive and HAART patients (2001) (54)
Phylogenetic Patterns of Human Respiratory Picornavirus Species, Including the Newly Identified Group C Rhinoviruses, during a 1-Year Surveillance of a Hospitalized Patient Population in Italy (2010) (54)
Rapid serotyping of human rotavirus strains by solid-phase immune electron microscopy (1984) (53)
Human cytomegalovirus UL131A, UL130 and UL128 genes are highly conserved among field isolates (2006) (53)
Correlation between immunofluorescent detection of human cytomegalovirus immediate early antigens in polymorphonuclear leukocytes and viremia. (1989) (53)
Inconsistent Responses of Cytomegalovirus‐Specific T Cells to pp65 and IE‐1 versus Infected Dendritic Cells in Organ Transplant Recipients (2007) (52)
Distribution of VP4 gene alleles in human rotaviruses by using probes to the hyperdivergent region of the VP4 gene (1993) (52)
Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients (1995) (51)
Epstein–Barr virus (EBV) load and interleukin‐10 in EBV‐positive and EBV‐negative post‐transplant lymphoproliferative disorders (2003) (50)
Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients (1998) (49)
Molecular epidemiology of primary human cytomegalovirus infection in pregnant women and their families (2008) (49)
Rising Levels of Human Cytomegalovirus (HCMV) Antigenemia during Initial Antiviral Treatment of Solid-Organ Transplant Recipients with Primary HCMV Infection (1998) (49)
Development and evaluation of a capture ELISA for IgM antibody to the human cytomegalovirus major DNA binding protein. (1991) (49)
Human cytomegalovirus (HCMV) DNAemia in the mother at amniocentesis as a risk factor for iatrogenic HCMV infection of the fetus. (2008) (48)
Human parechovirus infections in patients admitted to hospital in Northern Italy, 2008–2010 (2012) (47)
Preemptive Therapy for Systemic and Pulmonary Human Cytomegalovirus Infection in Lung Transplant Recipients (2009) (47)
Prenatal diagnosis of congenital human cytomegalovirus infection (1994) (47)
Prophylaxis followed by preemptive therapy versus preemptive therapy for prevention of human cytomegalovirus disease in pediatric patients undergoing liver transplantation. (2008) (46)
Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial1 (2003) (46)
Polo-Like Kinase 1 as a Target for Human Cytomegalovirus pp65 Lower Matrix Protein (1999) (46)
HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes. (1993) (45)
Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples (1995) (44)
Human Cytomegalovirus Cell Tropism and Host Cell Receptors (2019) (43)
Clinically‐based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients (2004) (43)
HCV genotyping by three methods: analysis of discordant results based on sequencing. (1999) (43)
Diagnosis of human cytomegalovirus infection of the nervous system by pp65 detection in polymorphonuclear leukocytes of cerebrospinal fluid from AIDS patients. (1994) (43)
Human Cytomegalovirus (HCMV)-Specific CD4+ and CD8+ T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-Organ Transplant Recipients (2014) (43)
Characterization of serotypes of human rotavirus strains by solid-phase immune electron microscopy. (1985) (43)
Human cytomegalovirus immediate-early messenger RNA in blood of pregnant women with primary infection and of congenitally infected newborns. (2001) (42)
Electropherotypes, subgroups and serotypes of human rotavirus strains causing gastroenteritis in infants and young children in Palermo, Italy, from 1985 to 1989. (1990) (42)
Lack of transmission to polymorphonuclear leukocytes and human umbilical vein endothelial cells as a marker of attenuation of human cytomegalovirus (2002) (41)
Identification of two subtypes of serotype 4 human rotavirus by using VP7-specific neutralizing monoclonal antibodies (1988) (41)
Immunoglobulin G to virus-specific early antigens in congenital, primary, and reactivated human cytomegalovirus infections (1978) (40)
A comparison of methods for detecting adenovirus type 8 keratoconjunctivitis during a nosocomial outbreak in a Neonatal Intensive Care Unit. (2003) (40)
Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells. (2003) (40)
Multicluster nosocomial outbreak of parainfluenza virus type 3 infection in a pediatric oncohematology unit: a phylogenetic study (2009) (40)
Human respiratory syncytial virus (hRSV) RNA quantification in nasopharyngeal secretions identifies the hRSV etiologic role in acute respiratory tract infections of hospitalized infants (2007) (39)
High frequency of Epstein–Barr virus (EBV) lymphoblastoid cell line‐reactive lymphocytes in cord blood: evaluation of cytolytic activity and IL‐2 production (1997) (39)
Human cytomegalovirus pp65 lower matrix phosphoprotein harbours two transplantable nuclear localization signals. (1996) (39)
Mutations in the UL97 ORF of ganciclovir-resistant clinical cytomegalovirus isolates differentially affect GCV phosphorylation as determined in a recombinant vaccinia virus system. (2002) (39)
Maternal immune correlates of protection from human cytomegalovirus transmission to the fetus after primary infection in pregnancy (2017) (39)
Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine. (2019) (39)
Prenatal Diagnosis of Congenital Human Cytomegalovirus Infection in Amniotic Fluid by Nucleic Acid Sequence-Based Amplification Assay (2003) (38)
Human and bovine serotype G 8 rotaviruses may be derived by reassortment (2005) (38)
Kinetics of Effector Functions and Phenotype of Virus-Specific and γδ T Lymphocytes in Primary Human Cytomegalovirus Infection During Pregnancy (2011) (38)
Serotype 3 human rotavirus strains with subgroup I specificity (1990) (37)
Coinfection of the immunocompromised but not the immunocompetent host by multiple human cytomegalovirus strains (1998) (37)
A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates. (1992) (37)
Prevalence of human rotavirus serotypes in some European countries 1981-1988. (1990) (37)
The attenuated Towne strain of human cytomegalovirus may revert to both endothelial cell tropism and leuko- (neutrophil- and monocyte-) tropism in vitro. (2002) (37)
Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. (2005) (36)
Four dually resistant human cytomegalovirus strains from AIDS patients: single mutations in UL97 and UL54 open reading frames are responsible for ganciclovir- and foscarnet-specific resistance, respectively. (1995) (36)
Prenatal diagnostic and prognostic value of human cytomegalovirus load and IgM antibody response in blood of congenitally infected fetuses. (1999) (36)
Human cytomegalovirus (HCMV) infection in paediatric patients given allogeneic bone marrow transplantation: role of early antiviral treatment for HCMV antigenaemia on patients' outcome. (1994) (36)
Slow increase in IgG avidity correlates with prevention of human cytomegalovirus transmission to the fetus. (2013) (35)
Management of human cytomegalovirus infection in transplantation: validation of virologic cut-offs for preemptive therapy and immunological cut-offs for protection. (2011) (35)
Prenatal treatment of congenital human cytomegalovirus infection by fetal intravascular administration of ganciclovir. (1993) (35)
Antigenic and biological relationships between human coronavirus OC43 and neonatal calf diarrhoea coronavirus. (1981) (34)
Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact. (2003) (34)
Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection. (2015) (34)
Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients. (1998) (33)
Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host. (2009) (33)
Multicenter quality control study for human cytomegalovirus DNAemia quantification. (2009) (33)
Cytomegalovirus DNAemia in pregnant women. (2014) (32)
Diagnosis and implications of human cytomegalovirus infection in pregnancy (1999) (31)
Group- and type-specific serologic response in infants and children with primary rotavirus infections and gastroenteritis caused by a strain of known serotype. (1990) (31)
In vitro model for the study of the dissociation of increasing antigenemia and decreasing DNAemia and viremia during treatment of human cytomegalovirus infection with ganciclovir in transplant recipients. (2003) (31)
Prospective study of human metapneumovirus infection: diagnosis, typing and virus quantification in nasopharyngeal secretions from pediatric patients. (2007) (30)
Comparative magnitude and kinetics of human cytomegalovirus‐specific CD4+ and CD8+ T‐cell responses in pregnant women with primary versus remote infection and in transmitting versus non‐transmitting mothers: Its utility for dating primary infection in pregnancy (2016) (30)
The human bocavirus role in acute respiratory tract infections of pediatric patients as defined by viral load quantification. (2007) (30)
Amino acids involved in distinguishing between monotypes of rotavirus G serotypes 2 and 4. (1996) (29)
Nevirapine-selected mutations Y181I/C of HIV-1 reverse transcriptase confer cross-resistance to stavudine (2003) (29)
Early virus isolation, early structural antigen detection and DNA amplification by the polymerase chain reaction in polymorphonuclear leukocytes from AIDS patients with human cytomegalovirus viraemia. (1991) (28)
Isolation in Europe of 69 M-like (serotype 8) human rotavirus strains with either subgroup I or II specificity and a long RNA electropherotype (2005) (28)
Human Cytomegalovirus and Human Umbilical Vein Endothelial Cells: Restriction of Primary Isolation to Blood Samples and Susceptibilities of Clinical Isolates from Other Sources to Adaptation (2002) (28)
Correlation of quantitative human cytomegalovirus pp65-, p72- and p150-antigenemia, viremia and circulating endothelial giant cells with clinical symptoms and antiviral treatment in immunocompromised patients. (1993) (28)
Human cytomegalovirus-specific T cell reconstitution in young patients receiving T cell-depleted, allogeneic hematopoietic stem cell transplantation. (2009) (28)
Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients. (2012) (28)
Human Cytomegalovirus UL131-128 Genes Are Indispensable for Virus Growth in Endothelial Cells and Virus Transfer to Leukocytes (2009) (28)
The pentameric complex of human Cytomegalovirus: cell tropism, virus dissemination, immune response and vaccine development. (2017) (27)
Enterovirus Genotype EV-104 in Humans, Italy, 2008–2009 (2010) (27)
Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets. (1995) (27)
Immunoperoxidase technique for detection of antibodies to human cytomegalovirus (1976) (26)
A comparison of the VP7 gene sequences of human and bovine rotaviruses. (1994) (26)
Human Coronavirus OC43 Serum Inhibitor and Neutralizing Antibody by a New Plaque-Reduction Assay 1 (1980) (26)
Emergence of a ganciclovir-resistant human cytomegalovirus strain with a new UL97 mutation in an AIDS patient. (1998) (26)
Phylogenetic analysis of rubella virus isolated during a period of epidemic transmission in Italy, 1991-1997. (2003) (25)
Synergistic neutralization of rubella virus by monoclonal antibodies to viral haemagglutinin. (1987) (25)
Clinical Evaluation of a Chemiluminescence Immunoassay for Determination of Immunoglobulin G Avidity to Human Cytomegalovirus (2004) (25)
Nevirapine Resistance Mutation at Codon 181 of the HIV-1 Reverse Transcriptase Confers Stavudine Resistance by Increasing Nucleotide Substrate Discrimination and Phosphorolytic Activity* (2003) (25)
Comparative sensitivities of solid-phase immune electron microscopy and enzyme-linked immunosorbent assay for serotyping of human rotavirus strains with neutralizing monoclonal antibodies (1988) (24)
Use of the human cytomegalovirus (HCMV) antigenemia assay for diagnosis and monitoring of HCMV infections and detection of antiviral drug resistance in the immunocompromised. (1998) (23)
Nosocomial outbreak of neonatal gastroenteritis caused by a new serotype 4, subtype 4B human rotavirus (1990) (23)
Acyclovir resistance/susceptibility in herpes simplex virus type 2 sequential isolates from an AIDS patient. (1991) (22)
Human Enteric Coronaviruses: Further Characterization and Immunoblotting of Viral Proteins (1987) (22)
Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host. (2015) (22)
Quantification of the impact of HIV-1 reverse transcriptase and protease mutations on the efficacy of rescue HAART. (2000) (22)
Detection of a new HIV-1 reverse transcriptase mutation (Q145M) conferring resistance to nucleoside and non-nucleoside inhibitors in a patient failing highly active antiretroviral therapy. (2003) (21)
Multiple relapses of human cytomegalovirus retinitis during HAART in an AIDS patient with reconstitution of CD4+ T cell count in the absence of HCMV-specific CD4+ T cell response. (2003) (21)
Ganciclovir therapy of congenital human cytomegalovirus hepatitis (1995) (21)
Heart rate and cardiac allograft vasculopathy in heart transplant recipients. (2011) (21)
Sharp drop in the prevalence of human cytomegalovirus leuko-DNAemia in HIV-infected patients following highly active antiretroviral therapy. (1998) (21)
Gln145Met/Leu Changes in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Resistance to Nucleoside and Nonnucleoside Analogs and Impair Virus Replication (2004) (21)
Simultaneous detection and typing of human metapneumovirus strains in nasopharyngeal secretions and cell cultures by monoclonal antibodies (2005) (20)
Phenotype and specificity of T cells in primary human cytomegalovirus infection during pregnancy: IL-7Rpos long-term memory phenotype is associated with protection from vertical transmission (2017) (20)
Detection and Characterization of Novel Rotavirus Strains in the United States (1999) (20)
Comparative evaluation of a commercial enzyme-linked immunoassay and solid-phase immune electron microscopy for rotavirus detection in stool specimens (1987) (20)
Human cytomegalovirus double resistance in a donor-positive/recipient-negative lung transplant patient with an impaired CD4-mediated specific immune response. (2004) (20)
Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus (1990) (19)
Optimized detection of respiratory viruses in nasopharyngeal secretions. (2003) (19)
Antibody to early antigens of varicella-zoster virus during varicella and zoster. (1979) (19)
Identification of a human cytomegalovirus mutant in the pp150 matrix phosphoprotein gene with a growth-defective phenotype. (1993) (19)
Determination of neutralizing antibody and IgG antibody to varicella-zoster virus and of IgG antibody to membrane antigens by the immunoperoxidase technique. (1977) (19)
A 6-hour microneutralization assay for human cytomegalovirus antibody by using monoclonal antibodies (1990) (18)
Microneutralization as a reference method for selection of the cut-off of an enzyme-linked immunosorbent assay for detection of IgG antibody to human cytomegalovirus. (1992) (18)
Genetic variation in rotavirus serotype 4 subtypes. (1992) (18)
Human cytomegalovirus (HCMV)‐specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid‐organ transplant recipients (2018) (18)
Declining Levels of Rescued Lymphoproliferative Response to Human Cytomegalovirus (HCMV) in AIDS Patients With or Without HCMV Disease Following Long‐Term HAART (2001) (18)
Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy. (2016) (18)
Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects. (2015) (18)
Identification of human cytomegalovirus isolates by the polymerase chain reaction. (1990) (17)
Expression of bovine rotavirus neutralization antigen in Escherichia coli. (1987) (17)
Determination of coronavirus 229E antibody by an immune‐adherence hemagglutination method (2005) (16)
Circulating cytomegalic endothelial cells are associated with high human cytomegalovirus (HCMV) load in AIDS patients with late‐stage disseminated HCMV disease (1998) (16)
Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union Concerted Action on Virus Meningitis and Encephalitis. (1998) (16)
Genomes of the endothelial cell‐tropic variant and the parental Toledo strain of human cytomegalovirus are highly divergent (2003) (16)
Three-year experience with human cytomegalovirus infections in heart transplant recipients. (1990) (16)
Diagnosis of human cytomegalovirus infections in the immunocompromised host. (1996) (16)
Early Identification of Human Cytomegalovirus Strains by the Shell Vial Assay Is Prevented by a Novel Amino Acid Substitution in UL123 IE1 Gene Product (2003) (16)
Serotype G6 human rotavirus sharing a conserved genetic constellation with natural reassortants between members of the bovine and AU-1 genogroups (2005) (15)
Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART. (2001) (15)
Human cytomegalovirus load measurement and its applications for pre‐emptive therapy in patients undergoing hematopoietic stem cell transplantation (2008) (15)
Giant cells produced by mitotic reversion in prophase, metaphase, anaphase, after low doses of X-rays. (1966) (15)
Diagnosis and monitoring of human cytomegalovirus infection in transplant recipients (2001) (15)
Evidence that human cytomegalovirus assembly protein shares antigenic sites with an uninfected cell membrane protein. (1991) (15)
Endonuclear Mitotic Spindle in the Leptomonad of Leishmania tropica (1969) (15)
Varicella-zoster plaque assay and plaque reduction neutralization test by the immunoperoxidase technique (1976) (15)
Rapid detection of human cytomegalovirus and herpesvirus hominis IgM antibody by the immunoperoxidase technique. (1977) (15)
Analysis of the SARS-CoV-2 epidemic in Italy: The role of local and interventional factors in the control of the epidemic (2020) (15)
Higher levels of HIV DNA in memory and naive CD4(+) T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAART. (2001) (14)
Z-isomers of 2-hydroxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol) are active against ganciclovir- and foscarnet-resistant human cytomegalovirus UL97 mutants. (2002) (14)
Molecular Characterization of Human Rotavirus VP4 Genes by Polymerase Chain Reaction and Restriction Fragment Length Polymorphism Assay (1993) (14)
Nosocomial outbreak of infant rotavirus diarrhea due to the appearance of a new serotype 4 strain (1989) (14)
Emergence of multiple drug-resistant human cytomegalovirus variants in 2 patients with human immunodeficiency virus infection unresponsive to highly active antiretroviral therapy. (2002) (14)
Antigenic Relatedness of Human Enteric Coronavirus Strains to Human Coronavirus OC43: A Preliminary Report (1984) (14)
The outer capsid glycoprotein VP7 of simian rotavirus SA11 contains two distinct neutralization epitopes. (1988) (14)
Rapid detection of human rotavirus strains in stools by single-sandwich enzyme-linked immunosorbent assay systems using monoclonal antibodies. (1989) (13)
Follicular helper T-cells and virus-specific antibody response in primary and reactivated human cytomegalovirus infections of the immunocompetent and immunocompromised transplant patients. (2016) (13)
Use of CMV transcripts for monitoring of CMV infections in transplant recipients. (2000) (13)
Detection of human cytomegalovirus DNA: how, when and where? (1995) (13)
Subgroup I serotype 3 human rotavirus strains with long RNA pattern as a result of naturally occurring reassortment between members of the bovine and AU-1 genogroups (2005) (13)
Solid-phase immune electron microscopy and enzyme-linked immunosorbent assay for typing of human rotavirus strains by using polyclonal and monoclonal antibodies: a comparative study. (1989) (13)
Rapid typing, subtyping and RNA quantification of influenza virus type A strains in respiratory secretions. (2008) (13)
Immunoglobulin M to the membrane of uninfected fibroblasts in primary human cytomegalovirus infections. (1986) (13)
An overview of letermovir: a cytomegalovirus prophylactic option (2019) (12)
Maternal, fetal and neonatal diagnosis of congenital human cytomegalovirus infection. (2008) (12)
Congenital rubella infection following rubella outbreak in northern Italy, 2002: need for an effective vaccination programme (2004) (12)
Intravitreal and Systemic Foscarnet in the Treatment of Aids-Related Cmv Retinitis (1996) (12)
Amino acid insertions at position 35 of HIV-1 protease interfere with virus replication without modifying antiviral drug susceptibility. (2006) (12)
Quantitative systemic and local evaluation of the antiviral effect of ganciclovir and foscarnet induction treatment on human cytomegalovirus gastrointestinal disease of patients with AIDS. Italian Foscarnet GID Study Group. (1997) (12)
Comparative quantification of human cytomegalovirus DNA in blood of immunocompromised patients by PCR and Murex Hybrid Capture System. (1997) (12)
NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine. (2007) (11)
Comparison of levels of HIV-1 resistance to protease inhibitors by recombinant versus conventional virus phenotypic assay and two genotypic interpretation procedures in treatment-naive and HAART-experienced HIV-infected patients. (2003) (11)
Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients. (2016) (11)
Grouping of human adenoviruses by early antigen reactivity. (1982) (11)
Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients (Journal of Medical Virology (2006) 78, (408-416)) (2008) (11)
Interferon-γ Increases Expression of Chemokine Receptors CCR1, CCR3, and CCR5, But Not CXCR4 in Monocytoid U937 Cells (1998) (11)
Isolation and Characterization of Two Distinct Human Rotavirus Strains with G 6 Specificity (11)
Nucleotide sequence comparison of the VP8* gene of rotaviruses possessing the AU-1 gene 4 allele. (1993) (11)
Circulating cytomegalic endothelial cells are associated with high human cytomegalovirus (HCMV) load in AIDS patients with late-stage disseminated HCMV disease. (1998) (10)
Comparative Analysis of Human Cytomegalovirus-Specific CD4+ T-Cell Frequency and Lymphoproliferative Response in Human Immunodeficiency Virus-Positive Patients (2001) (10)
Reactivity of human coronavirus OC43 and neonatal calf diarrhoea coronavirus membrane-associated antigens. (1982) (10)
Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients. (2013) (10)
Monitoring of human cytomegalovirus (HCMV)-specific CD4+ T cell frequency by cytokine flow cytometry as a possible indicator for discontinuation of HCMV secondary prophylaxis in HAART-treated AIDS patients. (2004) (10)
Phylogenetic analysis of human coronavirus NL63 circulating in Italy (2008) (9)
Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host. (2010) (9)
The immunoperoxidase technique for rapid human cytomegalovirus identification (2005) (9)
Coronaviruses and gastroenteritis: evidence of antigenic relatedness between human enteric coronavirus strains and human coronavirus OC43. (1984) (9)
KAPOSI SARCOMA FOLLOWING THORACIC ORGAN TRANSPLANTATION: PREVALENCE, CORRELATION WITH HUMAN HERPES VIRUS 8 AND NEW THERAPEUTIC OPTIONS. (1999) (9)
Electropherotype heterogeneity within serotypes of human rotavirus strains circulating in Italy (2005) (8)
Human cytomegalovirus infection: diagnosis by antigen and DNA detection (1994) (8)
A rapid microneutralization test for antibody determination and serodiagnosis of human coronavirus OC43 infections (1979) (8)
Rapid detection of enteroviral RNA in cerebrospinal fluid (CSF) from patients with aseptic meningitis by reverse transcription-nested polymerase chain reaction. (1998) (7)
Endothelial cells and CMV dissemination. (2012) (7)
Hyperimmune globulin to prevent congenital CMV infection. (2014) (7)
Anticytomegalovirus T-cell clones. (1996) (7)
Prediction of endothelial cell tropism of human cytomegalovirus strains. (2006) (7)
Comparison of the T-cell response to human cytomegalovirus (HCMV) as detected by cytokine flow cytometry and QuantiFERON-CMV assay in HCMV-seropositive kidney transplant recipients. (2018) (7)
Typing of herpes simplex virus isolates by enzyme-linked immunosorbent assay: comparison between indirect and double-antibody sandwich techniques (1983) (7)
HIV-1 plasma variants encoding truncated reverse transcriptase (RT) in a patient with high RT-specific CD8+ memory T-cell response. (2009) (6)
Human Cytomegalovirus Congenital (cCMV) Infection Following Primary and Nonprimary Maternal Infection: Perspectives of Prevention through Vaccine Development (2020) (6)
Adoptive Transfer of Herpesvirusspecific Cytotoxic T Lymphocytes in Transplant Recipients. (2000) (6)
Development and evaluation of an ELISA using secreted recombinant glycoprotein B for determination of IgG antibody to herpes simplex virus. (1991) (6)
[Microelectronic research on Entamoeba invadens]. (1965) (6)
Novel recombinant phenotypic assay for clonal analysis of reverse transcriptase mutations conferring drug resistance to HIV-1 variants. (2004) (6)
Polyfunctional Analysis of Human Cytomegalovirus (HCMV)-Specific CD4+ and CD8+ Memory T-Cells in HCMV-Seropositive Healthy Subjects Following Different Stimuli (2014) (6)
Rubella antibody assay by the immunoperoxidase technique: comparison with the hemagglutination inhibition test for determination of immune status. (1976) (6)
Subacute sclerosing panencephalitis: detection of measles antibody in serum and cerebrospinal fluid by enzyme-linked immunosorbent assay, complement fixation and hemagglutination inhibition. (1987) (6)
Quantification and identification of polyomavirus DNA in blood and urine of renal transplant recipients. (2007) (6)
Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli. (2016) (6)
Detection of rubella virus antigen by one‐step time‐resolved fluoroimmunoassay and by enzyme immunoassay (1989) (6)
Neutralizing serum antibodies to serotype 6 human rotaviruses PA151 and PA169 in Ecuadorian and German children (1992) (6)
State of the Art and Trends in Cytomegalovirus Diagnostics (2012) (5)
Serodiagnosis of respiratory synctial virus infections in infants and young children by the immunoperoxidse technique (1980) (5)
Seroepidemiologic study of human coronavirus OC43 infections in Italy. (1978) (5)
Rubella IgM antibody determination: comparison of two indirect and two capture commercial enzyme immunoassays. (1987) (5)
Infants and Young Children by the Immunoperoxidase Technique (5)
Human Cytomegalovirus Genomes Sequenced Directly from Clinical Material: Variation, Multiple-Strain Infection, Recombination and Mutation (2018) (5)
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies. (2005) (5)
Diagnostic value of viral culture, polymerase chain reaction and western blot for HIV-1 infection in 218 infants born to HIV-infected mothers and examined at different ages. (1999) (5)
Use of reverse-transcription polymerase chain reaction for detection of rubella virus RNA in cell cultures inoculated with clinical samples. (1997) (5)
Dissociation of Serum and Liver Hepatitis C Virus RNA Levels in Patients Coinfected with Human Immunodeficiency Virus and Treated with Antiretroviral Drugs (2004) (4)
Herpes simplex virus latency in immunosuppressed mice. (1984) (4)
Antibody response of patas monkeys to experimental infection with Delta herpesvirus (1984) (4)
Herpes Simplex Virus and Human Cancer. III. Search for Relationship of Herpes Simplex Antibodies and Cervical Dysplasia and Labial Neoplasia (1983) (4)
Subgrouping of human rotavirus strains by complement fixation, indirect double-antibody sandwich enzyme-linked immunosorbent assay and solid-phase immune electron microscopy (2005) (4)
Control of human cytomegalovirus infection in patients infected with human immunodeficiency virus by high levels of specific CD8+ T-cells. (2007) (4)
Identification of human cytomegalovirus strain with immediate-early (IE) antigen-specific monoclonal antibody is prevented by point mutation in IE gene (1994) (4)
Higher Short-Term Virologic Efficacy of Three-Class Versus Two-Class Highly Active Antiretroviral Salvage Therapy in HIV-Infected Patients (2000) (4)
Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in blood leukocytes and aqueous humor of AIDS patients with HCMV retinitis (1994) (4)
Electropherotyping of human rotaviruses: An epidemiological survey of rotavirus infections in Sicily (1986) (4)
Interpreting Human Cytomegalovirus Antiviral Drug Testing: The Role of Mixed Virus Populations (1998) (4)
Determination of anti-p52 IgM and anti-gB IgG by ELISA as a novel diagnostic tool for detection of early and late phase of primary human cytomegalovirus infections during pregnancy. (2019) (4)
Rapid detection of respiratory syncytial virus in nasopharyngeal secretions by immunofluorescence and ELISA does not justify discontinuation of virus isolation. (1989) (4)
Assays for determination of HIV resistance to antiviral drugs. (2004) (4)
Herpes simplex virus-1-specific human cytotoxic T lymphocytes are induced in vitro by autologous virus-infected mononuclear cells. (1992) (4)
Human cytomegalovirus UL 131 A , UL 130 and UL 128 genes are highly conserved among field isolates Brief Report (4)
A novel sensitive assay to define immune status using short-term peripheral blood derived cell culture and dual-color flow cytometry. (1998) (4)
Viral infections in bone marrow transplant recipients: From the bench to the bedside (1998) (3)
Comparison of a new Light Diagnostics and the CMV Brite to an in-house developed human cytomegalovirus antigenemia assay. (2008) (3)
Diagnosis of acute non-bacterial gastroenteritis by rotavirus detection and serology. (1984) (3)
Convenient twice daily foscarnet in induction therapy of AIDS-associated cytomegalovirus retinitis. The Foscarnet Italian Study Group. (1997) (3)
Congenital Human Cytomegalovirus Infection: A Narrative Review of Maternal Immune Response and Diagnosis in View of the Development of a Vaccine and Prevention of Primary and Non-Primary Infections in Pregnancy (2021) (3)
Human cytomegalovirus immediate early-mRNAemia vs pp65-antigenemia for guiding pre- emptive therapy in children and young adults given hematopoietic stem cell transplantation: a prospective, randomized, open-label trial Short title: HCMV IEmRNA vs antigenemia for monitoring HSCT recipients (2003) (3)
Herpes simplex virus type-specific antibody determination by enzyme-linked immunosorbent assay in human sera (1988) (3)
Kinetics of virus-specific IgG and IgM antibody response in patas monkeys experimentally infected with Delta herpesvirus by enzyme-linked immunosorbent assay. (1984) (3)
Early T cell reconstitution and cytokine profile may help to guide a personalized management of human cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. (2021) (3)
Detection of Genotype-Specific Antibody Responses to Glycoproteins B and H in Primary and Non-Primary Human Cytomegalovirus Infections by Peptide-Based ELISA (2021) (3)
Short Communication Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells (2003) (3)
Antibody to human adenovirus early antigens during acute adenovirus infections (1981) (2)
Naïve T Cell-Derived CTL Recognize Atypical Epitopes of CMVpp65 with Higher Avidity Than CMV-Seropositive Donor-Derived CTL – a Basis for Treatment of Post-Transplant Viral Infection by Adoptive Transfer of T Cells From Virus-naïve Donors (2011) (2)
Serum and cerebrospinal fluid herpes simplex virus type 1 immunoglobulin G and M titers in four cases of herpes simplex encephalitis. (1990) (2)
Characterization of rotavirus subgroup-specific monoclonal antibodies and use in single-sandwich ELISA systems for rapid subgrouping of human strains (2005) (2)
Techniques for typing Herpesvirus hominis antibody: a comparison of inhibition of peroxidase-labelled antibody staining with inhibition of indirect haemagglutination and with microneutralisation. (1977) (2)
Pathology of erythroblastic mitosis in occupational benzenic erythropathy and erythrema. In vivo and in vitro studies. (1970) (2)
Brief molecular diagnostic criteria for human cytomegalovirus infection/disease (2019) (2)
A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus (2014) (2)
Slow cytomegalovirus‐specific CD4+ and CD8+ T‐cell differentiation: 10‐year follow‐up of primary infection in a small number of immunocompetent hosts (2020) (2)
Interpreting human cytomegalovirus antiviral drug susceptibility testing: the role of mixed virus populations. (1998) (2)
Nucleic Acid Sequence-Based Amplification Transplant Recipients as Determined by Transcript in Heart , Lung , and Bone Marrow Human Cytomegalovirus pp 67 Late Clinical Significance of Expression of (1999) (1)
Human cytomegalovirus-specific CD4+ and CD8+ T-cells in organ transplant recipients (2006) (1)
Factors affecting amplification of BK virus episomal vectors in human cells (2005) (1)
On the finding of " filamentous paranuclear structures " in Entamoeba histolytica in vivo. Electron microscope investigations. (1968) (1)
Nosocomial outbreak of acute infantile gastroenteritis due to newly circulating serotype 4 Rotavirus (1988) (1)
[Morphologic and dynamic aspects of the apparatus of the sphere in histiocyte and macrophage cultures in vitro: microcinematographic observations by phase contrast]. (1968) (1)
Management of human cytomegalovirus infection in transplant recipients by the pre-emptive therapy approach (2009) (1)
[The erythroblast in benzolic erythremia. Electron microscopic studies]. (1967) (1)
Advances in diagnosis of herpesvirus infections: clinical and therapeutic correlations (2002) (1)
[Nuclear DNA content of human embryonal fibroblasts (RU-1) in cultures infected with virulent and attenuated strains of rubella virus]. (1975) (1)
Rubella virus identification in primary and continuous monkey kidney cell cultures by immunoperoxidase technique (2005) (1)
Effects of x-rays on ploidy and locomotion rate of granuloblasts "in vitro" (phase-contrast microcinematographic studies). (1968) (1)
[Differential ultrastructural elements in human cytomegalovirus and Herpes simplex virus replication in cultures of human cells]. (1975) (1)
Fibroblast, Epithelial and Endothelial Cell-Derived Human Cytomegalovirus Strains Display Distinct Neutralizing Antibody Responses and Varying Levels of gH/gL Complexes (2023) (1)
qualitative pp65-antigenemia receiving haematopoietic stem cell transplantation as compared to reduces the number of pre-emptively treated children and young adults Use of a DNAemia cut-off for monitoring human cytomegalovirus infection (2013) (1)
Viral infections in immunocompromised patients. (1987) (1)
Ganciclovir (GCV) resistance caused by oral GCV in an heart transplant recipient with multiple HCMV strains in blood (1997) (1)
Type specificity and use of human sera for rapid typing of herpes simplex virus isolates by an indirect peroxidase-labeled antibody technique: a comparison with three other methods (2005) (1)
Specific activation of B-cell clones within the central nervous system in course of herpes simplex encephalitis. (1990) (1)
Surveillance of influenza virus B circulation in Northern Italy: summer-fall 2008 isolation of three strains and phylogenetic analysis. (2009) (1)
[Kinetics of incorporation of thymidine-H3 in cell cultures infected with rubella virus]. (1973) (1)
Management of human cytomegalovirus infection in pregnancy (2012) (0)
[The immunoperoxidase technic in the rapid identification of human cytomegalovirus on primary isolation]. (1975) (0)
[Ultrastructural features of Entamoeba histolytica. Electron microscopy studies]. (1966) (0)
Ultrastructure of kinetoflagellar apparatus in lepto-monad forms of Leishmania tró pica. (1968) (0)
[Experimental research on the antimitotic action of penicillinic acid]. (1967) (0)
Monitoring of HCMV infections and DHPG treatment in heart transplant recipients (HTRs) by the polymerase chain reaction (1991) (0)
[The problem of fecal elimination of hepatitis B antigen studied in the light of the presence of an intestinal inhibitor]. (1975) (0)
PATHOLOGY OF CYTOKINESIS BY X RAYS. (1966) (0)
V. The Pathogenesis of Particular Aspects of Cytological Erythroblastic Anomalies in Occupational Benzenic Erythropathy and Erythremia (1970) (0)
[Different ultrastructural models of adenovirus aggregation: their value in virological diagnosis]. (1975) (0)
Fifth International Conference on AIDS : the Scientific and Social Challenge; symposium; management of infections associated with HIV immunodeficiency (1989) (0)
VI. Proliferation Activity of Atypical Erythroblasts (1970) (0)
In vivo interactions between HCMV and peripheral blood leukocytes (1991) (0)
Kaposi’s sarcoma following thoracic organ transplantation: prevalence, correlation with human herpes virus 8 and new therapeutic options. (1999) (0)
[Importance of sulfhydryl functions in cytotoxicology and in the therapy of some diseases due to physical and chemical agents]. (1965) (0)
Comparative sensitivity of electrosyneresis, complement-fixation and latex agglutination methods in the detection of Australia antigen-HBAg-in 142 patients with acute viral hepatitis. (1973) (0)
Response: Human cytomegalovirus DNAemia and preemptive treatment of HCMV infection in children receiving hematopoietic stem-cell transplantation (2008) (0)
[Observations on the fine struture of Entamoeba histolytica in vitro and in experimental amebiasis in the rat. Ultrastructural research]. (1968) (0)
[Microcinematographic research on the morphogenesis of micro-erythroblasts by the effects of x-rays]. (1965) (0)
Gln145Met/Leu changes in HIV-1 RT confer resistance to nucleoside and non-nucleoside analogs and impair virus replication. (2004) (0)
The immunoperoxidase technique for the rapid identification of human cytomegalovirus strains on primary isolation. (1975) (0)
Serotyping ofCellCulture-Adapted Subgroup 2HumanRotavirus Strains byNeutralization (1984) (0)
[PSEUDO-AMITOSIS INDUCED BY X-RAYS IN ERYTHROPOIETIC CELLS "IN VITRO"]. (1965) (0)
Positive findings of hepatitis B antigen (HbAg) in blood in acute viral hepatitis in non-professional hospital personnel. (1974) (0)
[MORPHOGENESIS OF ERYTHROPOIETIC CELLS WITH TWO NUCLEI BY THE ACTION OF X-RAYS]. (1965) (0)
Ganciclovir (GCV) resistance due to a new mutation in the UL97 gene product in a HCMV isolate from an AIDS patient (1997) (0)
Comparison of liquid hybridization (LH) and DNA enzyme immunoassay (DEIA) as a specificity control for human cytomegalovirus (HCMV) DNA amplification product by the polymerase chain reaction (PCR) (1991) (0)
Epstein-Barr virus and Herpes simplex virus specific cytotoxic T-lymphocyte activity after bone marrow transplantation in pediatric patients: Pattern of recovery and correlation with virus-specific immune status of the donor (1994) (0)
[Presence of RNA intranuclear spheroid bodies in human embryonal fibroblasts infected with adenovirus: their possible significance]. (1972) (0)
Ultrastructure of Entamoeba gingivalis, human parasite, with particular reference to cytomorphological differential compared with E. histolytica. (1968) (0)
[Comparative sensitivity of the electrosyneresis, complement-fixation and latex-agglutination methods in determination of Australia antigen (HBAg) in 142 cases of acute viral hepatitis]. (1973) (0)
Title Page / Contents / Foreword (1970) (0)
Antibodies Against Neutralization Epitopes of Human Cytomegalovirus gH/gL/pUL128-130-131 Complex and Virus Spreading May Correlate with Virus Control In Vivo (2012) (0)
[Research on the antimitotic activity of a new colchicine derivative, deacetamidocolchicine]. (1965) (0)
[Evaluation of several clinical and laboratory parameters in 142 patients with acute viral hepatitis, in relation to the positive or non-positive tests for Australia antigen (HBAg)]. (1973) (0)
[Karyoplasmic differentiations of the "spheroid body" type in cultures in vitro infected with Toxoplasma gondii RH]. (1970) (0)
The fine structure of Entamoeba histolytica Laredo strain. (1967) (0)
MORPHOGENESIS OF BINUCLEATED ERYTHROPOIETIC CELLS BY THE ACTION OF X RAYS (1965) (0)
Ultra-structure of cystic form of Hartmannella castellanii. (1970) (0)
Ultrastructural aspects of multiplication of Toxoplasma gondii in pseudo-cysts. (1968) (0)
Polymerase chain reaction (PCR) and monoclonal antibody (MAb) for rapid detection of human cytomegalovirus (HCMV) in peripheral blood leukocytes (PBL) (1990) (0)
[Morphogenesis of multinucleated cells by means of x-rays. Phase contrast study on erythropoietic cells in vivo]. (1967) (0)
Human Cytomegalovirus–Speciﬁc Memory CD8 (cid:1) and CD4 (cid:1) T Cell Differentiation after Primary Infection (2008) (0)
Seasonal Factors in the Epidemiology of Typhoid Fever. Statistical Research. (1966) (0)
TECHNIQUES F OR TYPING HERPESVIRUS HOMINIS ANTIBODY: A COMPARISON OF INHIBITION OF INHIBITION OF INDIRECT HAEMAGGLUTINATIO N AND WITH MICRONEUTRALISAT ION PEROXIDASE-LABELLED ANTIBODY STAINING WITH (1977) (0)
Distribution ofVP4GeneAlleles inHumanRotaviruses by UsingProbes totheHyperdivergent Region oftheVP4Gene (1993) (0)
[Morphogenesis of supplementary (Jolly pseudo-bodies) micronuclei in irradiated erythropoietic cells. Cinemicrographic studies in contrast phase]. (1966) (0)
[Aspects of mitotic division in mast cells. (Phase contrast microcinematographic observations)]. (1965) (0)
Detection of polymorphisms of human cytomegalovirus (HCMV) isolates using polymerase chain reaction (PCR) and single strand conformation polymorphisms (SSCP) (1991) (0)
Abstract 67. Comparison of ELISA assay with hemagglutination inhibition and complement fixation for Subacute Sclerosing Panencephalitis (SSPE) diagnosis (1985) (0)
Human cytomegalovirus does not replicate in polymorphomuclear leukocytes harboring infectious virus and viral pp65, DNA and mRNAs (1999) (0)
Human Cytomegalovirus (HCMV) viremia: false negative results in an AIDS patient due to a point mutation in the IE1 gene (1993) (0)
P.023 Cytomegalovirus infection with a L595W and A692V mutation responsible for gancyclovir and possibly foscarnet resistance successfully treated by CMV hyperimmune globulins (2009) (0)
[Microelectronic and microcinematographic investigations on the anti-amebic action of aminosidine]. (1969) (0)
VIII. The Modifications of the Karyotype Induced by Benzene and the Problem of Erythro-Leukemogenesis (1970) (0)
[Quantitative study of the biological damage caused by pan-irradiation. I. Changes in the index of erythroblastic karyological anomalies (Iac) as a function of time and dose]. (1966) (0)
MORPHOGENESIS OF THE NUCLEAR ANOMALY FROM SMALL DOSES OF X RAYS (1965) (0)
A comparative study of glucidic metabolism in cell cultures infected with virulent and with attenuated strains of rubella virus. (1975) (0)
Nonvirionic inhibitor of DNA synthesis in human embryo fibroblast cell cultures infected with rubella virus. (1975) (0)
[Ultrastructural aspects of different species of Entamoeba with tetranucleate custs. Comparative microelectronic research]. (1968) (0)
The action of the endotoxin and of the O and Vi antigens of Salmonella typhi on some biological activities of histiocytes. (1967) (0)
[1:7 ratio in the distribution of adw and ayw subtypes in a population of HBs Ag-positive hepatitis patients in northern Italy]. (1975) (0)
On the finding of " intranuclear capsulated spheroid bodies" in in vitro cell infection with Toxoplasma gondii'. (1969) (0)
II. Materials and Methods (1970) (0)
IV. Physiopathological Problems of Mitosis (1970) (0)
[Various ways of acquiring the pericapsule at the nuclear membrane level by Herpes simplex virus and human cytomegalovirus]. (1975) (0)
[ON THE MECHANISM OF THE ANAPHASIC SEPARATION OF CHROMATIDS AT THE LEVEL OF THE CENTROMERIC ZONE. MICRO-CINEMATOGRAPHIC RESEARCH ON ERYTHROBLASTS IN THE VITAL STATE]. (1963) (0)
[Maturation of the Rubella virus in cell cultures infected by virulent and attenuated strains. Ultrastructural study]. (1973) (0)
[Study of the index of infection (I inf) caused by Toxoplasma gondii in cultures in vitro of CS-C-l cells. Its changes in relation to graded doses of pyrimethamine]. (1970) (0)
Virological and Immunological Monitoring of Human Cytomegalovirus (HCMV) Infection in Hematopoietic Stem Cell Transplantation Recipients (HSCTR) (2019) (0)
[Inflammatory cellular reactions in patients with neoplasms treated with high energy radiotherapy]. (1967) (0)
[CONTRIBUTION TO THE STUDY OF THE PROLIFERATING ACTIVITY OF EHRLICH ASCITES TUMOR]. (1963) (0)
[Late stages in the replicative cycle of human cytomegaloviruses in diploid cells. Ultrastructural study]. (1975) (0)
Diagnosis of Disseminated Human Cytomegalovirus (HCMV) Infection in Patients with AIDS (1991) (0)
Ultra-structural aspects of cytopathogenic action of Toxoplasma gondii. (1968) (0)
Evaluation of some clinical and laboratory data concerning 142 patients with acute viral hepatitis in relation to the finding or otherwise of Australia antigen (HBAg). (1973) (0)
Human Cytomegalovirus (HCMV) systemic infections in AIDS patients by PCR (1991) (0)
Correlations between HCMV viremia, antigenemia, DNAemia and clinical symptoms (1992) (0)
VII. Morphogenetic Aspects of the Modifications of the Karyotype Induced by Benzene and Observed in Erythremia, and the Relations Between Cellular Karyotype and Phenotype (1970) (0)
Polymerase chain reaction (PCR) in the study of cytomegalovirus viremia (1990) (0)
[Morphogenesis of nuclear anomalies due to small doses of X rays]. (1965) (0)
[Determination of anti-cytomegalovirus antibodies by the immunoperoxidase method: comparison with the methods of complement fixation and immunofluorescence]. (1975) (0)
[Mechanisms of formation of annular nuclei in histocytes and macrophages. Studies by phase contrast microcinematography]. (1967) (0)
Acyclovir resistance in HSV-2 isolates from a patient with AIDS (1991) (0)
Polyfunctional Analysis of Human Cytomegalovirus (HCMV)-Specific CD4+ and CD8+ Memory T-Cells in HCMV-Seropositive Healthy Subjects Following Different Stimuli (2014) (0)
Corrigendum to Follicular helper T-cells and virus-specific antibody response in primary and reactivated human cytomegalovirus infections of the immunocompetent and immunocompromised transplant patients. (2016) (0)
In vivo identification of leukocyte subpopulations infected by human cytomegalovirus (HCMV) by mean of fluorescence activated cell sorting (FACS) and polymerase chain reaction (PCR) (1991) (0)
[Significance of anti-HTLV-III antibodies]. (1985) (0)
Ultrastnictural features of Entamoeba histolytica. Electromicrographic studies. (1966) (0)
[Contribution to the study of the rupture of the heart in acute myocardial infarct]. (1967) (0)
[Antibiotic treatment and hematopoiesis in human typhoid infections. Comparative studies on the effect of thiaphenicole and chloramphenicol]. (1968) (0)
[Evaluation of the antimitotic activity of the rubella virus (virulent Judith strain) on primary and stabilized cell cultures]. (1972) (0)
A simple method for human cytomegalovirus (HCMV) DNA quantitation in clinical samples (1993) (0)
ASPECTS OF MITOTIC PATHOLOGY FROM X RAYS AND MORPHOGENESIS OF HETEROPLOIDY IN GRANULOBLASTS: IN VITRO STUDIES USING PHASE-CONTRAST ACCELERATED MICROCINEMATOGRAPHY. (1968) (0)
T Cell-Mediated Control of HCMV Infection in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation. (2004) (0)
[Quantitative study of the biological damage caused by pan-irradiation. II. Statistical findings on the nature of the dose-effect relationship]. (1967) (0)
PSEUDO-AMITOSES PROVOKED BY X RAYS IN ERYTHROPOIETIC CELLS IN VITRO (1965) (0)
Early virus isolation, immediate-early antigen detection and DNA ampli¬fication by PCR in polymorphonuclear leukocytes from AIDS patients with human cytomegalovirus viremia (1990) (0)
Identifying high-confidence variants in human cytomegalovirus genomes sequenced from clinical samples (2022) (0)
[Ultrastructure of Toxoplasma gondii in pseudocysts]. (1969) (0)
NaïVe T Cells From Cord Blood and CMV-Seronegative Donors Recognize Atypical Epitopes of Cmvpp65 and Can Be Used for Adoptive Immunotherapy (2011) (0)
[Ultrastructural aspects of Entamoeba moshkovskii Tshalaia, 1941]. (1968) (0)
[Distribution of HB s Ag subtypes in a sample of acute viral hepatitis of type B in Northern Italy]. (1976) (0)
Observations on the fine structure of Entamoeba histolytica in vitro and in the experimental infection of the rat. Electron microscopic studies. (1968) (0)
Molecular characterization of human rotavirus VP4 genes by polymerase chain reaction and restriction fragment length polymorphism assay. (1993) (0)
[Treatment of carcinoma of the lung with a 42MeV betatron. Preliminary observations on 56 cases]. (1968) (0)
[Certain aspects of the morphogenesis of the heteroploid cells from abnormal mitosis caused by x-rays. (Microphotographic and microcinematographic studies in phase contrast of erythroblastic karyokinesis of live Triturus)]. (1967) (0)
Prophylaxis versus preemptive therapy for prevention of human cytomegalovirus disease in pediatric liver transplant recipients (2009) (0)
[On 2 "tumors" of the mediastinum. Clinico-diagnostic contribution based on 22 cases]. (1967) (0)
[Erythroblastometric research on the bone marrow of irradiated subjects]. (1967) (0)
Erratum: Detection and characterization of novel rotavirus strains in the United States (Journal of Clinical Microbiology (1998) 36:11 (3223- 3229)) (1999) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Giuseppe Gerna?

Giuseppe Gerna is affiliated with the following schools:

Giuseppe Gerna's Academic­Influence.com Rankings

Giuseppe Gerna's Degrees

Similar Degrees You Can Earn

Why Is Giuseppe Gerna Influential?

Giuseppe Gerna's Published Works

Published Works

What Schools Are Affiliated With Giuseppe Gerna?

Giuseppe Gerna's AcademicInfluence.com Rankings